Medrad Envision CT Injector System
by Medrad, Inc.
510(k) K993728
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK993728 | Date26 Nov 1999 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXT
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1650
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
The Medrad Envision CT Injector System is an angiographic injector and syringe system designed for the controlled delivery of contrast media. It functions as a flow-controlled fluid delivery system that allows operators to select specific flow rates for contrast administration during computed tomography procedures.
This device is intended for use in clinical settings to provide control over contrast injection into the patient. It is supplied as a system component and is subject to FDA 510(k) authorization under regulation number 870.1650.
Other devices from Medrad, Inc.
Questions
AI-generated answers, 27 Sep 2026
What is the primary function of the Medrad Envision CT Injector System?
This device is a flow-controlled fluid delivery system designed for the controlled administration of contrast media during computed tomography procedures, allowing operators to select specific flow rates.
What is the regulatory status of this device?
The Medrad Envision CT Injector System is subject to FDA 510(k) authorization under regulation number 870.1650.
In what clinical environment is this system intended to be used?
The system is intended for use in clinical settings to provide precise control over contrast injection into the patient during diagnostic imaging procedures.